| Primary |
| Tuberculosis |
66.7% |
| Meningitis Tuberculous |
33.3% |
|
| Blood Alkaline Phosphatase Increased |
14.3% |
| Encephalopathy |
14.3% |
| Jaundice |
14.3% |
| Liver Injury |
14.3% |
| Medication Error |
14.3% |
| Rash |
14.3% |
| Vomiting |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Tuberculosis |
10.8% |
| Prophylaxis Against Transplant Rejection |
7.2% |
| Drug Use For Unknown Indication |
6.3% |
| Psoriatic Arthropathy |
6.3% |
| Tuberculin Test Positive |
6.3% |
| Hiv Infection |
5.4% |
| Pulmonary Tuberculosis |
5.4% |
| Psoriasis |
4.5% |
| Glaucoma |
3.6% |
| Mucormycosis |
3.6% |
| Rheumatoid Arthritis |
3.6% |
| Ankylosing Spondylitis |
2.7% |
| Blood Cholesterol Increased |
2.7% |
| Crohn's Disease |
2.7% |
| Myelodysplastic Syndrome |
2.7% |
| Tuberculosis Skin Test Positive |
2.7% |
| Antibiotic Prophylaxis |
1.8% |
| Bladder Spasm |
1.8% |
| Blood Pressure |
1.8% |
|
| Neuropathy Peripheral |
8.6% |
| Renal Failure Acute |
8.6% |
| Drug Hypersensitivity |
5.7% |
| Fatigue |
5.7% |
| Hepatic Enzyme Increased |
5.7% |
| Hepatic Pain |
5.7% |
| Hypersensitivity |
5.7% |
| Liver Function Test Abnormal |
5.7% |
| Nervous System Disorder |
5.7% |
| Pancreatitis |
5.7% |
| Rash |
5.7% |
| Rheumatoid Arthritis |
5.7% |
| Spondylitis |
5.7% |
| Bilirubin Conjugated Increased |
2.9% |
| Blood Glucose Increased |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Drug Ineffective |
2.9% |
| Hepatotoxicity |
2.9% |
| Pruritus |
2.9% |
| Tuberculosis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.8% |
| Drug Use For Unknown Indication |
18.2% |
| Rheumatoid Arthritis |
13.1% |
| Crohn's Disease |
4.6% |
| Hiv Infection |
4.6% |
| Prophylaxis |
4.4% |
| Tuberculosis |
4.2% |
| Ankylosing Spondylitis |
3.7% |
| Uveitis |
3.7% |
| Antibiotic Prophylaxis |
2.8% |
| Depression |
2.3% |
| Psoriatic Arthropathy |
2.1% |
| Psoriasis |
1.9% |
| Sleep Disorder |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Pain |
1.6% |
| Tuberculin Test Positive |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Hypertension |
1.2% |
|
| Tuberculosis |
8.1% |
| Weight Decreased |
8.1% |
| Hepatic Enzyme Increased |
6.5% |
| Injection Site Pain |
6.5% |
| Pyrexia |
6.5% |
| Respiratory Failure |
6.5% |
| Tooth Extraction |
6.5% |
| X-ray Abnormal |
6.5% |
| Diarrhoea |
4.8% |
| Herpes Zoster |
4.8% |
| Pain |
4.8% |
| Pulmonary Embolism |
4.8% |
| Abortion Spontaneous |
3.2% |
| Alanine Aminotransferase Increased |
3.2% |
| Blood Albumin Decreased |
3.2% |
| Demyelination |
3.2% |
| Dyspnoea |
3.2% |
| Lung Disorder |
3.2% |
| Nausea |
3.2% |
| Nervous System Disorder |
3.2% |
|
| Interacting |
| Tuberculosis |
75.0% |
| Convulsion |
25.0% |
|
|
